The SMI index is showing signs of strength due to a technical recovery, as investors await important data from the US. However, UBS and Polypeptide stocks are declining, and Tecan is facing pressure.
In China, the Caixin/S&P Global PMI for the manufacturing sector has indicated a rise in October, suggesting a gradual improvement in the economy. Despite this positive sign, the labor market continues to face difficulties, and price levels remain low.
Senior economist Wang Zhe has emphasized that achieving China's growth target for 2024 depends on a sustained recovery in consumer demand, and policy efforts should effectively increase household disposable income. The Shanghai Stock Exchange has reported a 0.6 percent gain, reaching 3,299.61 points, while the index of major companies in Shanghai and Shenzhen has risen by 0.9 percent to 3,924.96 points.